{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:11Z","timestamp":1786119431134,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This study aimed to investigate the distinct subtypes of anoikis in hepatocellular carcinoma (HCC) and their underlying molecular mechanisms, and to construct a prognostic risk model. The gene expression profiles of HCC were downloaded from the cancer genome atlas and gene expression omnibus database, while anoikis-related genes were obtained from the GeneCards database. Unsupervised clustering algorithms were applied based on the expression of differentially expressed anoikis genes to identify related subtypes. Survival curves were used to analyze the differences in survival between subtypes, and the enrichment pathways and immune microenvironment differences were explored. Limma analysis, Cox proportional hazards regression analysis, and Least absolute shrinkage and selection operator regression algorithms were utilized to identify genes affecting the prognosis of subtypes and to construct a prognostic model, while also classifying high and low-risk groups for immune correlation analysis. The study identified 2 subtypes, C1 and C2, which showed significant differences in survival probability, enriched pathways, and immune microenvironment. SFN, BUB1, BSG, and HMOX1 were identified as prognostic genes, and a prognostic model was successfully constructed. There were significant differences in prognosis, expression of prognostic genes, and immune microenvironment between the high-risk and low-risk groups. The identification of different subtypes of anoikis in HCC and the construction of a prognostic model provide new insights and directions for the treatment and prognosis research of HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048503","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:04:09Z","timestamp":1777273449000},"page":"e48503","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identification of anoikis-related subtypes in hepatocellular carcinoma and construction of prognostic model: Construction of prognostic model"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5245-8650","authenticated-orcid":false,"given":"Xifeng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Emergency, The Affiliated Hospital of Putian University, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Putian University, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxian","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Putian University, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Putian University, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenting","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Putian University, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260622","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5582\/bst.2022.01061","article-title":"The clinical management of hepatocellular carcinoma worldwide: a concise review and comparison of current guidelines: 2022 update.","volume":"16","author":"Wen","year":"2022","journal-title":"Bioscience Trends"},{"key":"R2-20260622","doi-asserted-by":"crossref","first-page":"12536","DOI":"10.3390\/ijms241612536","article-title":"Possible therapies for hepatocellular carcinoma-preparing for the modern war with the insidious enemy.","volume":"24","author":"Wasilewicz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R3-20260622","doi-asserted-by":"crossref","first-page":"1083069","DOI":"10.3389\/fimmu.2023.1083069","article-title":"Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma.","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"R4-20260622","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/cbin.11970","article-title":"Understanding and targeting anoikis in metastasis for cancer therapies.","volume":"47","author":"Sattari Fard","year":"2023","journal-title":"Cell Biol Int"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"116878","DOI":"10.1016\/j.biopha.2024.116878","article-title":"Pharmacologically inducing anoikis offers novel therapeutic opportunities in hepatocellular carcinoma.","volume":"176","author":"Wang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R6-20260622","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.21037\/tcr-23-2096","article-title":"A novel anoikis-related gene signature can predict the prognosis of hepatocarcinoma patients.","volume":"13","author":"Yu","year":"2024","journal-title":"Transl Cancer Res"},{"key":"R7-20260622","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3892\/mmr.2024.13203","article-title":"Combining a glycolysis\u2011related prognostic model based on scRNA\u2011Seq with experimental verification identifies ZFP41 as a potential prognostic biomarker for HCC.","volume":"29","author":"Teng","year":"2024","journal-title":"Mol Med Rep"},{"key":"R8-20260622","doi-asserted-by":"crossref","first-page":"1323199","DOI":"10.3389\/fimmu.2024.1323199","article-title":"Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.","volume":"15","author":"Ouyang","year":"2024","journal-title":"Front Immunol"},{"key":"R9-20260622","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.3390\/ijms25115584","article-title":"The role of metabolic reprogramming in the tumor immune microenvironment: mechanisms and opportunities for immunotherapy in hepatocellular carcinoma.","volume":"25","author":"Hu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R10-20260622","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3892\/ijo.2024.5636","article-title":"Role of STAT3 in cancer cell epithelial\u2011mesenchymal transition (Review).","volume":"64","author":"Zhang","year":"2024","journal-title":"Int J Oncol"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"106311","DOI":"10.1016\/j.phrs.2022.106311","article-title":"STAT3-EMT axis in tumors: modulation of cancer metastasis, stemness and therapy response.","volume":"182","author":"Sadrkhanloo","year":"2022","journal-title":"Pharmacol Res"},{"issue":"Pt 4","key":"R12-20260622","doi-asserted-by":"crossref","first-page":"117390","DOI":"10.1016\/j.bcp.2025.117390","article-title":"Exon 13 skipping mediated by HNRNPL facilitates truncated SLK-induced metastasis in hepatocellular carcinoma.","volume":"242","author":"Guo","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"R13-20260622","doi-asserted-by":"crossref","first-page":"119025","DOI":"10.1016\/j.biopha.2026.119025","article-title":"RNA splicing dysregulation in hepatocellular carcinoma: molecular mechanisms, therapeutic targets, and intervention strategies-a comprehensive review.","volume":"195","author":"Xiong","year":"2026","journal-title":"Biomed Pharmacother"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"2115655","DOI":"10.1080\/2162402X.2022.2115655","article-title":"CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment.","volume":"11","author":"Lecoq","year":"2022","journal-title":"Oncoimmunology"},{"key":"R15-20260622","doi-asserted-by":"crossref","first-page":"1345838","DOI":"10.3389\/fimmu.2024.1345838","article-title":"Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point?","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"R16-20260622","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1186\/s12951-024-02888-5","article-title":"Hypoxic glioma-derived exosomal miR-25-3p promotes macrophage M2 polarization by activating the PI3K-AKT-mTOR signaling pathway.","volume":"22","author":"Xue","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"R17-20260622","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1038\/s41598-024-55086-6","article-title":"Development of a promising PPAR signaling pathway-related prognostic prediction model for hepatocellular carcinoma.","volume":"14","author":"Shi","year":"2024","journal-title":"Sci Rep"},{"key":"R18-20260622","doi-asserted-by":"crossref","first-page":"912694","DOI":"10.3389\/fonc.2022.912694","article-title":"Stemness analysis uncovers that the peroxisome proliferator-activated receptor signaling pathway can mediate fatty acid homeostasis in sorafenib-resistant hepatocellular carcinoma cells.","volume":"12","author":"Feng","year":"2022","journal-title":"Front Oncol"},{"key":"R19-20260622","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.","volume":"18","author":"Sun","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R20-20260622","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1038\/s41467-025-58809-z","article-title":"Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation.","volume":"16","author":"Liu","year":"2025","journal-title":"Nat Commun"},{"key":"R21-20260622","doi-asserted-by":"crossref","first-page":"996","DOI":"10.7150\/thno.51646","article-title":"The 14-3-3\u03c3 protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1\/2 signaling pathway.","volume":"11","author":"Song","year":"2021","journal-title":"Theranostics"},{"key":"R22-20260622","doi-asserted-by":"crossref","first-page":"9731675","DOI":"10.1155\/2023\/9731675","article-title":"Stratifin promotes hepatocellular carcinoma progression by modulating the Wnt\/\u03b2-catenin pathway.","volume":"2023","author":"Ye","year":"2023","journal-title":"Int J Genomics"},{"key":"R23-20260622","doi-asserted-by":"crossref","first-page":"100178","DOI":"10.1016\/j.cellin.2024.100178","article-title":"Stratifin-mediated activation of AKT signaling and therapeutic targetability in hepatocellular carcinoma progression.","volume":"3","author":"Hua","year":"2024","journal-title":"Cell Insight"},{"key":"R24-20260622","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1186\/s12876-025-04423-8","article-title":"Nitidine chloride inhibits colorectal cancer by targeting BUB1: mechanistic insights from molecular dynamics simulation, spatial transcriptomics, and single-cell RNA sequencing.","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R25-20260622","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1479-5876-12-190","article-title":"Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma.","volume":"12","author":"Wu","year":"2014","journal-title":"J Transl Med"},{"key":"R26-20260622","doi-asserted-by":"crossref","first-page":"377","DOI":"10.21147\/j.issn.1000-9604.2016.03.13","article-title":"CD147\/Basigin: a Warburg oncogene in hepatocellular carcinoma?","volume":"28","author":"Calvisi","year":"2016","journal-title":"Chin J Cancer Res"},{"key":"R27-20260622","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00262-019-02457-y","article-title":"Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma.","volume":"69","author":"Li","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"R28-20260622","doi-asserted-by":"crossref","first-page":"e34367","DOI":"10.1097\/MD.0000000000034367","article-title":"Development of a prognostic signature based on anoikis-related genes in hepatocellular carcinoma with the utilization of LASSO-cox method.","volume":"102","author":"Yu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R29-20260622","doi-asserted-by":"crossref","first-page":"9451557","DOI":"10.1155\/2022\/9451557","article-title":"HMOX1 attenuates the sensitivity of hepatocellular carcinoma cells to sorafenib via modulating the expression of ABC transporters.","volume":"2022","author":"Zhu","year":"2022","journal-title":"Int J Genomics"},{"key":"R30-20260622","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.18632\/aging.202492","article-title":"High expression of heme oxygenase-1 in tumor-associated macrophages characterizes a poor-prognosis subtype in nasopharyngeal carcinoma.","volume":"13","author":"Huang","year":"2021","journal-title":"Aging (Milano)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:08:24Z","timestamp":1786039704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":30,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048503","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"2024-11-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}